Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.7, 2009-07, pp. : 1077-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine

By Gurwitz D. Weizman A. Rehavi M.

Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. : 122-125

Elsevier

Access to resources Recommend Favorite

Personalized therapy and pharmacogenomics: future perspective

By Siest Géérard Marteau Jean-Brice Visvikis-Siest Sophie

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 927-930

Future Medicine

Access to resources Recommend Favorite

Conference Scene: Pharmacogenomics: paving the path to personalized medicine

By Patrinos George P Innocenti Federico

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 141-146

Future Medicine

Access to resources Recommend Favorite

The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine

Current Drug Metabolism, Vol. 12, Iss. 5, 2011-06 ,pp. : 460-486

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 3, 2017-04 ,pp. : 221-230

Bentham Science Publishers

Access to resources Recommend Favorite